eastsidehunky.wordpress.com
FDA approves second biosimilar; Copaxone copy Glatopa launch pending, uncertain
Well, we now have two biosimilars approved in the US with the FDA’s marketing approval of Sandoz / Momenta’s copycat version of Copaxone for relapsing-forms of multiple sclerosis (RRMS), a chronic …
